Showing 851-860 of 8579 results for "".
Physician Spotlight: Steven R. Feldman, MD, PhD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-steven-r-feldman-md-phd/20779/Amid roadblocks, opportunities exist to improve adherence among dermatology patientsWardrobe
Malfunctionhttps://practicaldermatology.com/topics/practice-management/wardrobe-malfunction/20913/Top dermatologists share tips on dressing for success.Physician Spotlight: Amy McMichael, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-amy-mcmichael-md/21178/Effectively Manage Older Patients with Skin Diseases
https://practicaldermatology.com/topics/psoriasis/effectively-manage-older-patients-with-skin-diseases/21749/As the population ages, staying abreast of the latest developments in geriatric dermatology is critical.Managing Acne and Rosacea in the Aesthetic Patient
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/managing-acne-and-rosacea-in-the-aesthetic-patient/23732/Sometimes patients seeking aesthetic interventions don’t even realize there is help for their inflamed skin.Women in Dermatology With Doris Day, MD
https://practicaldermatology.com/columns/physician-spotlight/women-in-dermatology-with-doris-day-md/23236/How Ichthyosis Can Affect Mental Health—And How We Can Address It
https://practicaldermatology.com/programs/practical-dermatology/how-ichthyosis-can-affect-mental-health-and-how-we-can-address-it/24029/As a rare condition, ichthyosis can bring additional burdens upon patients and caregivers alike.Close Up With Emma Guttman-Yassky, MD, PhD
https://practicaldermatology.com/topics/close-up/close-up-with-emma-guttman-yassky-md-phd/23953/Physician Spotlight: R. Rox Anderson, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-r-rox-anderson-md/23838/A Growing Neuromodulator Market: Daxxify Approved
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/a-growing-neuromodualtor-market-daxxify-approved/23797/Revance Therapeutics’ DaxibotulinumtoxinA-lanm is now approved to treat glabellar lines.